Sandra Milligan
CIK 1859810 · Interim CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$428.1K
Companies
4
Total Filings
26
Lifetime Open-Market Net
$75.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GOSS | Director | 90,050 | $0.16 | $14.6K | $75.2K | 8 | 2026-06-05 |
| SYRE | Director | — | $80.79 | — | $0 | 3 | 2026-05-29 |
| Aspira Women's Health Inc. (AWH) Delisted | Interim CEO | 13,644 | $0.08 | $1.1K | $0 | 5 | 2025-01-29 |
| OGN | Head of Research & Development | 30,767 | $13.44 | $413.5K | $0 | 10 | 2023-05-08 |
Recent Filings · Page 3 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-03 | OGN | Mixed | +1,356 | -$17.5K | EDGAR |
| 2022-04-04 | OGN | Grant (A) | — | $0 | EDGAR |
| 2022-03-02 | OGN | Mixed | +7,230 | -$110.5K | EDGAR |
| 2021-08-19 | OGN | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | OGN | Grant (A) | — | $0 | EDGAR |
Showing 21–26 of 26
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.